Nano-X Imaging (NNOX) Change in Accured Expenses (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Change in Accured Expenses of -$2.1 million for Q1 2026, down 129.92% year-on-year from $7.1 million in Q1 2025, and down 186.63% on a QoQ basis from $2.4 million in Q4 2025.
Nano-X Imaging (NNOX) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Change in Accured Expenses for 6 consecutive years, with -$2.1 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Accured Expenses fell 129.92% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12000.0 (up 90.84% YoY) and the FY2025 annual result came in at $1.2 million, up 141.22% from the prior year.
- Change in Accured Expenses retreated to -$2.1 million in Q1 2026 per NNOX's latest filing, from $2.4 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for NNOX reached as high as $10.0 million in Q4 2022 and fell as low as -$8.5 million in Q4 2023.
- A 5-year average of $59588.2 and a median of -$298000.0 in 2024 frame the typical range for Change in Accured Expenses.
- The largest YoY upside for Change in Accured Expenses was 47980.0% in 2022 against a maximum downside of 905.41% in 2022.
- Year by year, Change in Accured Expenses stood at $10.0 million in 2022, then tumbled by 184.92% to -$8.5 million in 2023, then soared by 106.65% to $564000.0 in 2024, then surged by 332.45% to $2.4 million in 2025, then plunged by 186.63% to -$2.1 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$2.1 million, $2.4 million, and -$417000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.11 Mn |
| Mar 31, 2026 | -2.11 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | -417,000.00 |
| Sep 30, 2025 | -417,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | -919,000.00 |
| Mar 31, 2025 | -919,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Dec 31, 2024 | 564,000.00 |
| Sep 30, 2024 | -99,000.00 |
| Sep 30, 2024 | -99,000.00 |
| Jun 30, 2024 | 323,000.00 |
| Jun 30, 2024 | 323,000.00 |
| Mar 31, 2024 | -298,000.00 |
| Mar 31, 2024 | -298,000.00 |
| Dec 31, 2023 | -8.48 Mn |
| Dec 31, 2023 | -8.48 Mn |